Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Novartis is developing an experimental drug for weight loss.

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.